Department of Obstetrics and Gynaecology, McMaster University, Hamilton, ON, Canada.
Department of Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada.
BJOG. 2017 Jul;124(8):1176-1189. doi: 10.1111/1471-0528.14624. Epub 2017 Apr 17.
Preterm birth (PTB) is the leading cause of infant death, but it is unclear which intervention is best to prevent it.
To compare progesterone, cerclage and pessary, determine their relative effects and rank them.
We searched Medline, EMBASE, CINAHL, Cochrane CENTRAL and Web of Science (to April 2016), without restrictions, and screened references of previous reviews.
We included randomised trials of progesterone, cerclage or pessary for preventing PTB in women with singleton pregnancies at risk as defined by each study.
We extracted data by duplicate using a piloted form and performed Bayesian random-effects network meta-analyses and pairwise meta-analyses. We rated evidence quality using GRADE, ranked interventions using SUCRA and calculated numbers needed to treat (NNT).
We included 36 trials (9425 women; 25 low risk of bias trials). Progesterone ranked first or second for most outcomes, reducing PTB < 34 weeks [odds ratio (OR) 0.44; 95% credible interval (CrI) 0.22-0.79; NNT 9; low quality], <37 weeks (OR 0.58; 95% CrI 0.41-0.79; NNT 9; moderate quality), and neonatal death (OR 0.50; 95% CrI 0.28-0.85; NNT 35; high quality), compared with control, in women overall at risk. We found similar results in the subgroup with previous PTB, but only a reduction of PTB < 34 weeks in women with a short cervix. Pessary showed inconsistent benefit and cerclage did not reduce PTB < 37 or <34 weeks.
Progesterone was the best intervention for preventing PTB in singleton pregnancies at risk, reducing PTB < 34 weeks, <37 weeks, neonatal demise and other sequelae.
Progesterone was better than cerclage and pessary to prevent preterm birth, neonatal death and more in network meta-analysis.
早产(PTB)是婴儿死亡的主要原因,但尚不清楚哪种干预措施最能预防早产。
比较孕酮、宫颈环扎术和宫颈扩张器,确定它们的相对效果并对其进行排序。
我们检索了 Medline、EMBASE、CINAHL、Cochrane 中心数据库和 Web of Science(截至 2016 年 4 月),没有任何限制,并对之前综述的参考文献进行了筛选。
我们纳入了孕酮、宫颈环扎术或宫颈扩张器用于预防单胎妊娠高危孕妇早产的随机试验,每个研究均有明确的定义。
我们使用预试验表格重复提取数据,并进行贝叶斯随机效应网络荟萃分析和成对荟萃分析。我们使用 GRADE 评估证据质量,使用 SUCRA 对干预措施进行排序,并计算需要治疗的人数(NNT)。
我们纳入了 36 项试验(9425 名女性;25 项低偏倚风险试验)。孕酮在大多数结局中排名第一或第二,降低了 <34 孕周早产的风险[比值比(OR)0.44;95%可信区间(CrI)0.22-0.79;NNT9;低质量]、<37 孕周早产(OR 0.58;95% CrI 0.41-0.79;NNT9;中等质量]和新生儿死亡(OR 0.50;95% CrI 0.28-0.85;NNT35;高质量),与对照组相比,整体处于风险中的女性。我们在既往有早产史的亚组中发现了类似的结果,但仅在宫颈短的女性中降低了<34 孕周早产的风险。宫颈扩张器的效果不一致,宫颈环扎术不能降低<37 孕周或<34 孕周早产的风险。
孕酮是预防风险单胎妊娠早产的最佳干预措施,可降低<34 孕周、<37 孕周、新生儿死亡及其他不良结局的发生风险。
在网络荟萃分析中,孕酮在预防早产、新生儿死亡和其他方面优于宫颈环扎术和宫颈扩张器。